Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The mm should be moving up the ask since it's being hit so much.
Well I don't like it either, but I guess that's what people do in the pennies
Buy the rumor sell the news apparently. Don't give up yet man. By the end of July we could be at the top of another pot stock bubble
I'm spreading the word about Abattis
Yeah I've been speaking to people who missed out last time about joining. A lot of people doing research at this stage. Definitely gonna bring in new buyers over the next few weeks. Not worried in the least.
My thought was that Washington legalization hype would sustain the price for the day. If I wasn't expecting anything out of this news I would have sold this morning. The stock is trading like it should.
Shorts are growing impatient
tasty volume
ask is getting slapped hard
big orders coming in
green close
holding up pretty well compared to the others
good thing I cancelled my order
PLAYER ME HAS ENTERED THE GAME
I put an order in. We'll see how it goes...
49.58% short after today. This may just pass .9 if those shorts panic tomorrow
I think I'll be buying here tomorrow morning
oooooh bummer down to .09
What the poop is going on over in HEMP land? I didn't see news. Is it just one of those days?
I give it 5 more minutes before we run up again
Do I buy now or has the run already finished for today? hmmmmmm I think this is probably a sell on the news and I don't see the pps moving back up much
Had an order in at 1.34, but decided to cancel. woooooops...
All over the place this morning
ABATTIS INFORMATION AVAILABLE ON S&P CAPITAL IQ
Vancouver, BC – July 7, 2014 - Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (OTC PINK: ATTBF) (CSE: ATT), a specialty biotechnology company focused on cultivating, licensing, and marketing proprietary ingredients, bio-similar compounds, equipment, and consulting services to North American medicinal markets, today announced that its company information would be made available via S&P Capital IQ Corporation Record’s Listing Program. This is one of the final steps in the Company elevating to the OTC QX in the upcoming months.
“We are excited to enhance our visibility within the investment community via the S&P Capital IQ’s program,” said Abattis Bioceuticals Corp. President & CEO Mike Withrow. “Our company is rapidly approaching a key tipping point with several subsidiaries moving forward with licensing through Health Canada. Management is committing to unlocking shareholder value through both operational excellence and increased market awareness through programs like these.”
As part of the program, a full description of Abattis Bioceuticals Corp. will be published in the Daily News Section of Standard & Poors’s Corporation Records, a recognized securities manual for secondary trading in up to 38 States under the Blue Sky Laws. S&P Capital IQ Corporation Records is available in print, CD-ROM, and via the web at www.netadvantage.standardandpoors.com as well as through numerous electronic vendors.
The company information about Abattis Bioceuticals Corp. to be made available through this program includes an in-depth description of the Abattis’ business operations, share price, dividend history, shares outstanding, company financial position, earnings, and full income statement and balance sheet.
About Abattis Bioceuticals Corp.
Abattis is a specialty biotechnology company with capabilities through its wholly owned subsidiaries of cultivating, licensing and marketing proprietary ingredients, bio-similar compounds, patented equipment and consulting services to medicinal markets in North America. The Company is positioned to capitalize on the fast growing trend toward marijuana legalization in the United States and for medicinal use in Canada and international jurisdictions, by supplying and partnering with companies to employ its mass cultivation systems, extraction equipment/technology, and strategic marketing support to licensed growers. The Company also has an extensive pipeline of high-quality products and intellectual property for the rapidly expanding botanical drug market. We follow strict standard operating protocols, and adhere to the applicable laws of Canada and foreign jurisdictions. For more information, visit the Company's website at: www.abattis.com.
About S&P Capital IQ
S&P Capital IQ, a business unit of McGraw Hill Financial (NYSE:MHFI), is a leading provider of multi-asset class and real time data, research and analytics to institutional investors, investment and commercial banks,
I believe page 3 just outlines what their future plans are, not that they're actually already set up.
I bet they'd rather dump the shares at 40 though ;)
That's what it looked like to me
How could I possibly forget that?!?!
Damn... Now I'm not so sure if there's even gonna be a pullback in the coming week. This is the first time since early April that ATTBF has been above the 20 and 30 day moving averages. I wouldn't be surprised to see this take off starting Monday. Strong Buy
ATTBF appears to be setting up for a small pullback on Wednesday or so. However, that's all I foresee... A small pullback. I don't think you'll be able to get shares much cheaper than .60. It crossed its 10, 20, and 30 day moving averages. Next stop 40 day ma is coming on Monday probably. On Tuesday it'll most likely be in overbought territory for 3 month period and need to regain stability. I'm really liking what I see here.
Thoughts? Criticisms?
Agreed. I plan on putting more into abattis and maybe vape until I see something happening here. It's the waiting that becomes costly. Time is money
What kind of gains are you looking for exactly? Because there are far less risky stocks to double your money on
Because this stock hasn't done anything recently. Maybe in a month or so things will be different. I'll definitely keep my eye on it, but other opportunities are available right now that I don't want to pass up due to being too stubborn to sell. Perhaps I'll be able to buy more shares of SPRWF with the gains I make elsewhere.
If that's your philosophy, get out of pink sheets. You're better off investing in growth sectors like 3D printing. Which, by the way, is on it's way up. I got out of SPRWF yesterday at .71 and I'm still kicking myself still that I waited when I knew there were other opportunities to take advantage of.
Well that just sounds stupid. Why on earth would you wait that long to turn a small profit? Learn to move on, man.
I'm willing to bet that the reason that the stock price went up in the first place was due to insiders exercising those stock options.
Expectation of good news is already built into the price. After such a massive upswing a little correction was needed. Price may remain flat until the positive news comes, but I doubt it. Should go up after Monday and continue with results of Washington sales.
I think I'll be buying Monday, but I'll have to examine this a bit more. The correction really hasn't been bad at all and seems to have slowed. Seems to have a bright future ahead.
Got out at .071 and holy shit I'm glad I did. The volume here is just crap. Nothing against the company for me, but I just got tired of waiting and waiting when there are much better plays out there for the near term.
Glad I got out of this one holy tits!